We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $39.1B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+1.04%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$18.4B
AUM Growth
+$120M
Cap. Flow
+$64.5M
Cap. Flow %
0.35%
Top 10 Hldgs %
43.98%
Holding
252
New
8
Increased
28
Reduced
110
Closed
4

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$285M
2
UNH icon
UnitedHealth
UNH
+$53.5M
3
GE icon
GE Aerospace
GE
+$36.4M
4
PEP icon
PepsiCo
PEP
+$12.5M
5
RL icon
Ralph Lauren
RL
+$10.1M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$39.4M
2
PM icon
Philip Morris
PM
+$20.6M
3
AAPL icon
Apple
AAPL
+$18.7M
4
KO icon
Coca-Cola
KO
+$17.7M
5
MO icon
Altria Group
MO
+$13.8M

Sector Composition

Rank Sector Weight
1 Consumer Staples 31.84%
2 Energy 18.16%
3 Financials 14.69%
4 Healthcare 10.53%
5 Technology 9.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PM icon
1
Philip Morris
PM
$311B
$1.62B 8.84%
16,711,214
-205,974
-1% -$20.6M
XOM icon
2
ExxonMobil
XOM
$649B
$1.08B 5.85%
12,318,584
+3,211,005
+35% +$285M
MO icon
3
Altria Group
MO
$125B
$1.07B 5.83%
16,956,067
-207,008
-1% -$13.8M
KO icon
4
Coca-Cola
KO
$383B
$1.06B 5.74%
24,949,772
-402,978
-2% -$17.7M
AAPL icon
5
Apple
AAPL
$5.04T
$695M 3.78%
24,609,396
-704,788
-3% -$18.7M
CVX icon
6
Chevron
CVX
$382B
$619M 3.37%
6,011,633
-133,664
-2% -$13.6M
TROW icon
7
T. Rowe Price
TROW
$25.7B
$532M 2.9%
8,007,118
-4,590
-0.1% -$320K
EPD icon
8
Enterprise Products Partners
EPD
$83.8B
$518M 2.82%
18,736,389
+158,449
+0.9% +$4.38M
PG icon
9
Procter & Gamble
PG
$338B
$505M 2.75%
5,630,250
-124,609
-2% -$10.8M
KMI icon
10
Kinder Morgan
KMI
$70.7B
$384M 2.09%
16,603,530
-113,164
-0.7% -$2.4M
META icon
11
Meta Platforms (Facebook)
META
$1.51T
$383M 2.09%
2,985,785
-68,268
-2% -$8.47M
PEP icon
12
PepsiCo
PEP
$196B
$346M 1.89%
3,185,439
+115,630
+4% +$12.5M
JPM icon
13
JPMorgan Chase
JPM
$927B
$337M 1.83%
5,060,136
+49,875
+1% +$3.25M
CB icon
14
Chubb
CB
$141B
$324M 1.77%
2,585,243
-37,581
-1% -$4.77M
MDLZ icon
15
Mondelez International
MDLZ
$83.4B
$304M 1.65%
6,918,472
-3,322
-0% -$146K
MCD icon
16
McDonald's
MCD
$193B
$297M 1.62%
2,579,855
-70,341
-3% -$8.34M
BNY
17
Bank of New York Mellon
BNY
$105B
$295M 1.61%
7,396,249
– –
MSFT icon
18
Microsoft
MSFT
$2.96T
$289M 1.57%
5,022,325
-119,577
-2% -$6.75M
TXN icon
19
Texas Instruments
TXN
$254B
$277M 1.51%
3,955,285
-178,350
-4% -$12.2M
JNJ icon
20
Johnson & Johnson
JNJ
$643B
$277M 1.51%
2,346,234
-49,909
-2% -$6.05M
ABBV icon
21
AbbVie
ABBV
$471B
$277M 1.5%
4,383,060
-127,384
-3% -$8.25M
CMCSA icon
22
Comcast
CMCSA
$88B
$269M 1.47%
8,118,822
-231,534
-3% -$7.71M
NVO
23
Novo Nordisk
NVO
$229B
$244M 1.33%
11,755,316
-380,772
-3% -$9.44M
WBA
24
DELISTED
Walgreens Boots Alliance
WBA
$240M 1.31%
2,982,206
-77,600
-3% -$6.33M
ABT icon
25
Abbott
ABT
$189B
$217M 1.18%
5,130,540
-135,180
-3% -$5.79M
1
2 3 4 5

Similar funds

Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Empower Advisory Group
Empower Advisory Group Greenwood Village, Colorado $38.5B AUM 18.4% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Fayez Sarofim & Co's Q3 2016 Portfolio in Review

As of Q3 2016, Fayez Sarofim & Co held 252 positions worth $18.4B, up 0.66% from $18.3B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Trading was light in Q3 2016: portfolio turnover was 4.8%. Fayez Sarofim & Co opened 8 new positions and exited 4, leaving the 252-position portfolio largely intact.

By sector, the portfolio is most concentrated in Consumer Staples at 32% of assets, down from 34% a quarter earlier, followed by Energy and Financials.

  • Fayez Sarofim & Co's largest Q3 2016 buy was UnitedHealth: 381,762 shares worth $53.3M.
  • Fayez Sarofim & Co added most to ExxonMobil in Q3 2016, an estimated $285M increase.
  • Fayez Sarofim & Co's biggest Q3 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $39.4M.
  • Fayez Sarofim & Co fully exited Rio Tinto in Q3 2016, selling an estimated $382K.
  • Fayez Sarofim & Co's ten largest holdings make up 44% of its $18.4B portfolio in Q3 2016.
  • Fayez Sarofim & Co opened 8 new positions and closed 4 in Q3 2016.
  • Fayez Sarofim & Co's portfolio value rose 0.66% quarter-over-quarter to $18.4B.

Based on Fayez Sarofim & Co's 13F filing for Q3 2016, filed 14 Nov 2016.